Rhythm Pharmaceuticals (RYTM) Free Cash Flow Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Rhythm Pharmaceuticals | 6.00 Bn | 5.66 Bn | 52.96 Mn | -6.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.60% |
| Dec 31, 2025 | 9.28% |
| Sep 30, 2025 | 17.31% |
| Jun 30, 2025 | 15.67% |
| Mar 31, 2025 | 9.12% |
| Dec 31, 2024 | 22.54% |
| Sep 30, 2024 | 14.45% |
| Jun 30, 2024 | 3.23% |
| Mar 31, 2024 | -6.70% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | -2.67% |
| Jun 30, 2023 | -11.39% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | -1.81% |
| Sep 30, 2022 | -11.61% |
| Jun 30, 2022 | -11.74% |
| Mar 31, 2022 | -18.64% |
| Dec 31, 2021 | -23.78% |
| Sep 30, 2021 | -32.63% |
| Jun 30, 2021 | -37.00% |
| Mar 31, 2021 | -42.26% |
| Dec 31, 2020 | -54.37% |
| Sep 30, 2020 | -47.54% |
| Jun 30, 2020 | -69.16% |
| Mar 31, 2020 | -72.64% |
| Dec 31, 2019 | -73.41% |